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A B S T R A C T
Cystic partially differentiated nephroblastoma (CPDN) and cystic nephroblastoma are paediatric renal tumours
characterised by the presence of a variable combination of primitive epithelium, immature stroma and blastema.
Cystic nephroblastoma can be identified by the presence of solid expansile areas of tumour which are absent in
CPDN. The distinction can pose diagnostic difficulty pre-operatively and is of paramount importance as their
metastatic potential, prognosis and hence therapeutic strategies differ.
We present a 2 year old girl, with two right renal masses, diagnosed pre-operatively as synchronous ne-
phroblastoma based on clinical, radiological and cytologic findings. Neo-adjuvant chemotherapy was adminis-
tered followed by nephrectomy. Two discrete tumours were present, one being an epithelial predominant ne-
phroblastoma and the other a CPDN. The CPDN showed an unusual spectrum of epithelial cells lining the cysts
including intestinal type epithelium with goblet cells.
This case represents one of three cases described thus far in the literature of concomitant nephroblastoma and
CPDN or cystic nephroma (CN) and is the only case in which nephroblastoma occurred synchronously with
CPDN. Due to neo-adjuvant therapy being instituted for the nephroblastoma, this case provides unique insights
into possible chemotherapy induced changes in a CPDN (usually treated by surgical excision alone).
This case highlights several important issues in paediatric cystic renal neoplasms, particularly the distinction
between cystic nephroma, CPDN and cystic nephroblastoma. The differential diagnosis of cystic paediatric renal
neoplasms is broad and requires appropriate clinical, radiological and histological assessment, often with an-
cillary immunohistochemical and molecular studies to arrive at a correct diagnosis. Histologic features of che-
motherapy effect, although well-described in nephroblastoma, are not well-described in CPDN. Based on our
knowledge of possible chemotherapy induced changes in nephroblastoma, such as maturation of epithelial and
stromal elements that may be so marked as to mimic mature teratoma, we hypothesize that this case demon-
strates such changes within a CPDN.
1. Introduction
1.1. Case report
A two year old girl, previously well, presented with an abdominal
mass which was felt by her mother two days prior to presentation.
There was one episode of vomiting and stool had not been passed in two
days. The mother reported that the child had lost weight, but could not
quantify the period or the amount of weight loss. On examination, the
child did not appear acutely or chronically unwell. Hypertension and a
resting tachycardia were noted. Moderate pallor was present, as well as
non-pathological cervical and inguinal lymph nodes. No dysmorphic
features were present. The anthropometry and clinical nutritional state
were normal. There was obvious flank asymmetry with a large, hard
and ballotable right upper quadrant mass palpable. No other abnorm-
alities were found.
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An ultrasound of the abdomen revealed two masses in the right
kidney. A well-defined round mass was seen in the right upper pole of
the kidney (4.7 cm in diameter). A large hyperechoic mass with a claw
sign was seen in the lower pole (7.2 × 5.5 × 6.4 cm).
An ultrasound-guided fine needle aspiration biopsy was performed
of the upper pole mass and a cytological diagnosis of nephroblastoma
was issued. The aspirate consisted predominantly of blastemal elements
with a few tubular structures and some stromal tissue fragments. The
lower pole mass was not aspirated. An MRI could only be obtained
following the fine needle biopsy and confirmed a heterogenous right-
sided upper pole mass with a well-defined capsule and a claw sign
(Fig. 1). The lower pole mass was well-defined and multi-cystic, with
internal septa and a fibrous capsule. No calcifications were seen. As-
sociated hydronephrosis and hypertrophy of the right kidney, and an
enlarged right renal artery were noted. There was no infiltration into
the right renal vein. In addition, another well-defined peripheral nodule
with associated restriction was seen adjacent to the lower pole mass in
the right kidney. This was consistent with a perilobar nephrogenic rest.
The left kidney was normal in size, but contained a small hyperintense
focus within the lower pole, suspicious for a nephrogenic rest.
These MRI findings were suspicious for synchronous ne-
phroblastoma in the right kidney, with right-sided nephrogenic rest and
renal hypertrophy, as well as a suspicious lesion in the left kidney. No
pulmonary lesions were seen on a CT scan of the chest. Based on these
findings of two synchronous renal masses, one of which was confirmed
on cytology to be a nephroblastoma, with a background of lesions
suspicious for nephrogenic rests, the final interpretation of this case was
that of synchronous nephroblastoma’s with background ne-
phroblastomatosis. Neo-adjuvant chemotherapy was thus instituted for
nephroblastoma (vincristine and actinomycin weekly for 4 weeks).
Following completion of the pre-operative chemotherapy, an ul-
trasound of the abdomen showed enlargement of the upper pole mass in
the right kidney (6 cm), as well as the lower pole mass
(7.5 × 7.5 × 9.4 cm). Hydronephrosis was still seen. An uncomplicated
right nephrectomy and excision biopsy of the left renal mass were
performed and the child made a full recovery from surgery.
Macroscopically, two discrete, well circumscribed masses were
present on coronal sectioning of the right nephrectomy specimen
(Fig. 2); one in the upper pole and one in the lower pole. These masses
were sharply demarcated from the adjacent renal parenchyma and had
no points of communication with one another. The smaller upper pole
lesion, which was sampled prior to neo-adjuvant therapy, measured
55 × 48 × 15 mm, was solid, uniform and pale grey to tan with no
haemorrhage, necrosis or cyst formation. The larger lower pole lesion
was entirely multicystic with no solid expansile areas and measured
115 × 130 × 130 mm.
Microscopic analysis of the upper pole tumour confirmed the pre-
sence of an epithelial predominant nephroblastoma with chemotherapy
effect (SIOP classification) [1]. The features included immature glo-
merular structures, primitive tubules and papillary structures sur-
rounded by a compressed fibrous pseudocapsule (Fig. 3). Residual
primitive stroma and blastema were absent, and no foci of anaplasia
were demonstrated. The features interpreted as chemotherapy effect
were a fibro-myxomatous stroma containing lipid- and hemosiderin-
laden macrophages as well as absence of the blastemal elements seen on
pre-therapy cytology (Fig. 4).
The lower pole tumour comprised multiple large cysts separated by
loose stroma with no solid or expansile foci despite extensive sampling.
Occasional compressed glomeruloid structures were present. The
Fig. 1. MRI of the abdomen showing two lesions in the right kidney: a solid
upper pole mass (white arrow) and a multicystic lower pole lesion (red arrow).
(For interpretation of the references to colors in this figure legend, the reader is
referred to the web version of this paper.)
Fig. 2. Macroscopy of the right nephrectomy specimen showing two tumours: a
solid upper pole lesion and a completely multicystic lower pole lesion.
Fig. 3. H&E 40x Epithelial predominant nephroblastoma (Upper pole tumour).
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intervening stroma appeared primitive and oedematous, featuring a
mild chronic inflammatory cell infiltrate. Blastema and mature stromal
elements were absent. The cysts were lined by a spectrum of epithelia
including attenuated cuboidal, low columnar, tall stratified columnar,
hobnailing, and intestinal mucinous epithelium with goblet cells
(Figs. 5–7).
The epithelial lining of the cysts in the lower pole lesion was posi-
tive for pancytokeratin (MNF-116), with focal positive staining for cy-
tokeratin 7 and 20, CDX2, P504S (Racemase), SALL4 and EMA.
Vimentin, CD56 and Glypican-3 were negative in the epithelium. The
compressed glomeruloid structures between cysts were positive for
WT1.
Hyperplastic perilobar nephrogenic rests were present in the back-
ground kidney, in keeping with the pre-operative MRI findings. The
lesion seen on MRI of the left kidney was a scar with renal cysts.
A final diagnosis of an upper pole epithelial predominant ne-
phroblastoma with chemotherapy effect and background hyperplastic
perilobar nephrogenic rests was made. The lower pole mass was diag-
nosed as a cystic partially differentiated nephroblastoma-like lesion
with a comment on the possible differential diagnoses (see discussion
below). The child received another 4 weeks of post-operative che-
motherapy (vincristine and actinomycin D) and is currently well, at-
tending a long-term follow-up clinic.
2. Discussion
We present an interesting case of a nephroblastoma with a syn-
chronous CPDN-like lesion and a background of hyperplastic ne-
phrogenic rests that was treated with neo-adjuvant chemotherapy. The
nephroblastoma was confirmed on pre-therapy cytology and at ne-
phrectomy showed an epithelial predominant nephroblastoma with
chemotherapy effect. The cystic lesion did not have pre-therapy cy-
tology/histology. Based on the imaging findings and the occurrence
with a confirmed nephroblastoma and suspected nephrogenic rests, this
cystic lesion was interpreted pre-operatively as most likely to be a
synchronous cystic nephroblastoma. Histology of this lesion however
showed only features of a CPDN with no solid expansile areas despite
extensive sampling. Interestingly this lesion also showed unusual epi-
thelial cells lining the cysts including intestinal type epithelium with
goblet cells. This case highlights several important issues in this setting
including the differential diagnosis of paediatric cystic renal neoplasms,
features that can be useful to distinguish these lesions from one an-
other, the histologic features seen in response to chemotherapy and the
possible concomitant occurrence of more than one of these lesions.
These issues are discussed below.
The differential diagnosis of multicystic paediatric renal masses is
broad and includes cystic nephroma (CN), cystic partially differentiated
nephroblastoma (CPDN), cystic nephroblastoma, cystic renal cell car-
cinoma, cystic congenital mesoblastic nephroma, localised cystic
kidney disease and although rarely cystic, clear cell sarcoma and renal
rhabdoid tumour. CN and CPDN are however the only two primary
Fig. 4. H&E 400x Chemotherapy induced changes in the nephroblastoma – fi-
bromyxoid stroma, hemosiderin laden macrophages and haemorrhage.
Fig. 5. H&E 40x lower pole lesion showing multiple cysts lined by a spectrum of
epithelial types including attenuated cuboidal, columnar and mucinous with
goblet cells.
Fig. 6. H&E 100x lower pole lesion showing multiple cysts lined by a spectrum
of epithelial types including attenuated cuboidal and columnar.
Fig. 7. H&E 100x lower pole lesion showing multiple cysts lined by a spectrum
of epithelial types including columnar and mucinous with goblet cells.
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paediatric cystic renal neoplasms that are exclusively cystic and should
therefore be strongly considered in cases with no solid areas [1]. Sev-
eral features that are unique to nephroblastoma may help to distinguish
it from these other differentials. These include the presence of bilateral
or multifocal disease, background nephrogenic rests, associated syn-
dromes (Denys-Drash, WAGR, Beckwith-Weideman) and the presence
of skeletal muscle, adipose tissue and neoplastic tubules. Patient age,
morphology and immunohistochemistry (such as INI1 in renal rhabdoid
tumour [2], BCOR in clear cell sarcoma [3], pan-TRK in mesoblastic
nephroma [4]), may help resolve the other differential considerations.
Cystic partially differentiated nephroblastoma was first described by
Brown in 1975 [5]. It represents a well demarcated discrete mass
composed entirely of cysts with an absence of solid areas [1,5]. The cyst
walls are lined by flattened to hobnailed epithelium with a variable
component of blastema, immature epithelium or immature stroma
within thin fibrous septa [1,5]. It occurs more commonly in males
under two years of age [6]. It is distinguished from CN by the presence
of embryonal cell types (blastema, immature epithelium or immature
stroma) within the septa [7]. CN and CPDN are both treated by surgical
excision alone and share an excellent prognosis [6,8].
Cystic nephroblastoma is distinguished from the former two entities
by the presence of a solid expansile mass(es) which distort the contours
of the cyst(s) and may comprise an admixture of blastema, immature
epithelium and primitive stroma, although one or more of these may
predominate [6]. Nephroblastoma is treated with surgery, che-
motherapy and radiotherapy (either pre-operatively or post-opera-
tively). The sequence of treatment modalities depends on the protocol
being followed (i.e. SIOP vs. COG protocols) [1]. CN and CPDN are
treated with surgical resection alone requiring no adjuvant che-
motherapy and the distinction of these lesions from nephroblastoma is
therefore of paramount importance [9].
In the past CN, CPDN and cystic nephroblastoma were considered to
be related tumours on a spectrum of differentiation [10]. Recent studies
into the biological profile of these tumours have however shown that
CN and CPDN are not related entities and importantly paediatric CN is
associated with DICER1 mutations [11]. It has been proposed, but never
proven, that nephroblastoma may undergo maturation to a CPDN
analogous to maturation of a neuroblastoma to a ganglioneuroma
[12,13]. The diagnostic challenges posed by these three neoplasms pre-
operatively and histologically is well known and has been the subject of
many articles [14,15].
Concomitant CN/CPDN and Wilms Tumour have been described
[16,17]. In one of these cases, a 9 month old infant presented with
bilateral cystic masses radiologically in keeping with CPDN [16]. Bi-
lateral partial nephrectomies were undertaken with histologic con-
formation of CPDN. Six months follow-up revealed recurrence of the
masses which were again excised. The histology of the recurrence was
that of cystic nephroblastoma. The second case occurred in a 21 month
old girl and presented as synchronous tumours separated by a fibrous
capsule [17]. Histology of the lesions was that of a triphasic ne-
phroblastoma and a CN. Our case is similar to the second case described
here in that the neoplasms were synchronous and both occurred in
slightly older children (21 and 24 months). Our case did however show
embryonal cells within the fibrous septae in keeping with CPDN.
Chemotherapy-induced changes are well described in ne-
phroblastoma and include necrosis of predominately mitotically active
blastemal components with potentially massive necrosis and shrinkage
of the tumour [18]. Maturation and differentiation of epithelial and
stromal components is also described and may mimic teratoma with
endodermal, ectodermal and mesenchymal differentiation [19,20].
Chemotherapeutic changes in CPDN and CN are not described in the
literature, as surgical excision is the treatment of choice. One of the
cases described above of a synchronous nephroblastoma and CN re-
ceived pre-operative neo-adjuvant chemotherapy. No treatment related
changes were described in the CN component although necrosis was
seen in the nephroblastoma [17].
There are two possible interpretations of the histologic findings in
our case. One, which we favour, is that of a nephroblastoma and a
concurrent CPDN. The other interpretation is that of synchronous ne-
phroblastoma’s, one of which was cystic, with extensive chemotherapy-
induced changes leaving no solid expansile areas behind. The pre-
therapy imaging of an exclusively multicystic lesion would favour the
first interpretation. Extensive chemotherapy induced changes in a ne-
phroblastoma resulting in morphology of a CPDN has not been de-
scribed in the literature. We hypothesize that the spectrum of epithelial
types seen in the CPDN, including intestinal epithelium with goblet
cells, represents chemotherapy induced changes as has been described
in nephroblastoma, but not to our knowledge previously in CPDN.
3. Conclusion
CPDN and nephroblastoma are paediatric renal neoplasms that de-
monstrate a variable combination of primitive epithelium, immature
stroma and blastema, and differ in the lack of solid expansile areas in
the former. The distinction is important as prognosis, rate of recurrence
and therapeutic strategies differ, with nephroblastoma potentially re-
quiring addition of chemotherapy and/or radiotherapy to surgical ex-
cision. Previous publications have highlighted the diagnostic difficulty
in distinguishing between CPDN and cystic nephroblastoma pre-op-
eratively [14]. The histologic distinction is made more difficult by the
addition of chemotherapy-induced changes in these lesions. We report
an unusual case of a CPDN with a concomitant nephroblastoma. We
hypothesize that the unusual finding of extensive intestinal type epi-
thelium lining cysts of the CPDN represents chemotherapy induced
changes in a CPDN that have not been previously described.
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